190 related articles for article (PubMed ID: 1312271)
1. Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus.
Lin YL; Borenstein LA; Selvakumar R; Ahmed R; Wettstein FO
Virology; 1992 Apr; 187(2):612-9. PubMed ID: 1312271
[TBL] [Abstract][Full Text] [Related]
2. Cottontail rabbit papillomavirus L1 protein-based vaccines: protection is achieved only with a full-length, nondenatured product.
Lin YL; Borenstein LA; Ahmed R; Wettstein FO
J Virol; 1993 Jul; 67(7):4154-62. PubMed ID: 7685411
[TBL] [Abstract][Full Text] [Related]
3. Intracutaneous vaccination of rabbits with the cottontail rabbit papillomavirus (CRPV) L1 gene protects against virus challenge .
Sundaram P; Tigelaar RE; Brandsma JL
Vaccine; 1997; 15(6-7):664-71. PubMed ID: 9178468
[TBL] [Abstract][Full Text] [Related]
4. Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease.
Reuter JD; Vivas-Gonzalez BE; Gomez D; Wilson JH; Brandsma JL; Greenstone HL; Rose JK; Roberts A
J Virol; 2002 Sep; 76(17):8900-9. PubMed ID: 12163609
[TBL] [Abstract][Full Text] [Related]
5. The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes.
Christensen ND; Kreider JW; Kan NC; DiAngelo SL
Virology; 1991 Apr; 181(2):572-9. PubMed ID: 1707567
[TBL] [Abstract][Full Text] [Related]
6. Protective cell-mediated immunity by DNA vaccination against Papillomavirus L1 capsid protein in the Cottontail Rabbit Papillomavirus model.
Hu J; Cladel NM; Budgeon LR; Reed CA; Pickel MD; Christensen ND
Viral Immunol; 2006; 19(3):492-507. PubMed ID: 16987067
[TBL] [Abstract][Full Text] [Related]
7. Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus.
Christensen ND; Reed CA; Cladel NM; Han R; Kreider JW
J Virol; 1996 Feb; 70(2):960-5. PubMed ID: 8551636
[TBL] [Abstract][Full Text] [Related]
8. Complete protection from papillomavirus challenge after a single vaccination with a vesicular stomatitis virus vector expressing high levels of L1 protein.
Roberts A; Reuter JD; Wilson JH; Baldwin S; Rose JK
J Virol; 2004 Mar; 78(6):3196-9. PubMed ID: 14990742
[TBL] [Abstract][Full Text] [Related]
9. Immunisation with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L1 gene provides protection from CRPV challenge.
Govan VA; Christensen ND; Berkower C; Jacobs WR; Williamson AL
Vaccine; 2006 Mar; 24(12):2087-93. PubMed ID: 16343704
[TBL] [Abstract][Full Text] [Related]
10. Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2.
Gambhira R; Jagu S; Karanam B; Gravitt PE; Culp TD; Christensen ND; Roden RB
J Virol; 2007 Nov; 81(21):11585-92. PubMed ID: 17715230
[TBL] [Abstract][Full Text] [Related]
11. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.
Breitburd F; Kirnbauer R; Hubbert NL; Nonnenmacher B; Trin-Dinh-Desmarquet C; Orth G; Schiller JT; Lowy DR
J Virol; 1995 Jun; 69(6):3959-63. PubMed ID: 7745754
[TBL] [Abstract][Full Text] [Related]
12. Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypes.
Kalnin K; Tibbitts T; Yan Y; Stegalkina S; Shen L; Costa V; Sabharwal R; Anderson SF; Day PM; Christensen N; Schiller JT; Jagu S; Roden RB; Almond J; Kleanthous H
Vaccine; 2014 Jun; 32(28):3540-7. PubMed ID: 24780250
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity to rabbit oral and cutaneous papillomaviruses by immunization with short peptides of L2, the minor capsid protein.
Embers ME; Budgeon LR; Pickel M; Christensen ND
J Virol; 2002 Oct; 76(19):9798-805. PubMed ID: 12208958
[TBL] [Abstract][Full Text] [Related]
14. Vesicular stomatitis virus-based therapeutic vaccination targeted to the E1, E2, E6, and E7 proteins of cottontail rabbit papillomavirus.
Brandsma JL; Shylankevich M; Su Y; Roberts A; Rose JK; Zelterman D; Buonocore L
J Virol; 2007 Jun; 81(11):5749-58. PubMed ID: 17392369
[TBL] [Abstract][Full Text] [Related]
15. T-cell response to cottontail rabbit papillomavirus structural proteins in infected rabbits.
Selvakumar R; Borenstein LA; Lin YL; Ahmed R; Wettstein FO
J Virol; 1994 Jun; 68(6):4043-8. PubMed ID: 8189540
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation.
Jansen KU; Rosolowsky M; Schultz LD; Markus HZ; Cook JC; Donnelly JJ; Martinez D; Ellis RW; Shaw AR
Vaccine; 1995 Nov; 13(16):1509-14. PubMed ID: 8578834
[TBL] [Abstract][Full Text] [Related]
17. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
18. Expression in Escherichia coli of seven DNA fragments comprising the complete L1 and L2 open reading frames of human papillomavirus type 6b and localization of the 'common antigen' region.
Strike DG; Bonnez W; Rose RC; Reichman RC
J Gen Virol; 1989 Mar; 70 ( Pt 3)():543-55. PubMed ID: 2471790
[TBL] [Abstract][Full Text] [Related]
19. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
[TBL] [Abstract][Full Text] [Related]
20. Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes.
Jagu S; Karanam B; Wang JW; Zayed H; Weghofer M; Brendle SA; Balogh KK; Tossi KP; Roden RBS; Christensen ND
Vaccine; 2015 Oct; 33(42):5553-5563. PubMed ID: 26382603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
